Cross-ancestry GWAS meta-analysis identifies six breast cancer loci in African and European ancestry women
- PMID: 34234117
- PMCID: PMC8263739
- DOI: 10.1038/s41467-021-24327-x
Cross-ancestry GWAS meta-analysis identifies six breast cancer loci in African and European ancestry women
Abstract
Our study describes breast cancer risk loci using a cross-ancestry GWAS approach. We first identify variants that are associated with breast cancer at P < 0.05 from African ancestry GWAS meta-analysis (9241 cases and 10193 controls), then meta-analyze with European ancestry GWAS data (122977 cases and 105974 controls) from the Breast Cancer Association Consortium. The approach identifies four loci for overall breast cancer risk [1p13.3, 5q31.1, 15q24 (two independent signals), and 15q26.3] and two loci for estrogen receptor-negative disease (1q41 and 7q11.23) at genome-wide significance. Four of the index single nucleotide polymorphisms (SNPs) lie within introns of genes (KCNK2, C5orf56, SCAMP2, and SIN3A) and the other index SNPs are located close to GSTM4, AMPD2, CASTOR2, and RP11-168G16.2. Here we present risk loci with consistent direction of associations in African and European descendants. The study suggests that replication across multiple ancestry populations can help improve the understanding of breast cancer genetics and identify causal variants.
Conflict of interest statement
The authors declare no competing interests.
References
Publication types
MeSH terms
Grants and funding
- U01 CA069417/CA/NCI NIH HHS/United States
- P30 ES010126/ES/NIEHS NIH HHS/United States
- R01 CA089085/CA/NCI NIH HHS/United States
- R01 CA142996/CA/NCI NIH HHS/United States
- Z01 ES044005/ImNIH/Intramural NIH HHS/United States
- R01 CA098663/CA/NCI NIH HHS/United States
- T32 GM008692/GM/NIGMS NIH HHS/United States
- P30 ES013508/ES/NIEHS NIH HHS/United States
- UM1 CA164974/CA/NCI NIH HHS/United States
- 16563/CRUK_/Cancer Research UK/United Kingdom
- R03 CA227357/CA/NCI NIH HHS/United States
- R01 CA100598/CA/NCI NIH HHS/United States
- P01 CA151135/CA/NCI NIH HHS/United States
- C1287/A16563/CRUK_/Cancer Research UK/United Kingdom
- P50 CA058223/CA/NCI NIH HHS/United States
- R01 CA100374/CA/NCI NIH HHS/United States
- R01 CA228198/CA/NCI NIH HHS/United States
- P20 CA233307/CA/NCI NIH HHS/United States
- R01 CA058420/CA/NCI NIH HHS/United States
- R01 CA242929/CA/NCI NIH HHS/United States
- K05 CA136967/CA/NCI NIH HHS/United States
- R01 CA063464/CA/NCI NIH HHS/United States
- C1287/A10118/CRUK_/Cancer Research UK/United Kingdom
- R37 CA054281/CA/NCI NIH HHS/United States